BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 8432412)

  • 1. Diabetes and embryonic malformations. Role of substrate-induced free-oxygen radical production for dysmorphogenesis in cultured rat embryos.
    Eriksson UJ; Borg LA
    Diabetes; 1993 Mar; 42(3):411-9. PubMed ID: 8432412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of rat embryos in culture media containing different concentrations of normal and diabetic rat serum.
    Styrud J; Eriksson UJ
    Teratology; 1992 Nov; 46(5):473-83. PubMed ID: 1462252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal antioxidant treatments prevent diabetes-induced alterations of mitochondrial morphology in rat embryos.
    Yang X; Borg LA; Simán CM; Eriksson UJ
    Anat Rec; 1998 Jul; 251(3):303-15. PubMed ID: 9669757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-Acetylcysteine and alpha-cyano-4-hydroxycinnamic acid alter protein kinase C (PKC)-delta and PKC-zeta and diminish dysmorphogenesis in rat embryos cultured with high glucose in vitro.
    Gäreskog M; Wentzel P
    J Endocrinol; 2007 Jan; 192(1):207-14. PubMed ID: 17210758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Free radical scavenging enzymes in fetal dysmorphogenesis among offspring of diabetic rats.
    Sivan E; Lee YC; Wu YK; Reece EA
    Teratology; 1997 Dec; 56(6):343-9. PubMed ID: 9485543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced SOD activity and increased neural tube defects in embryos of the sensitive but not of the resistant Cohen diabetic rats cultured under diabetic conditions.
    Weksler-Zangen S; Yaffe P; Ornoy A
    Birth Defects Res A Clin Mol Teratol; 2003 Jun; 67(6):429-37. PubMed ID: 12962287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal diabetes in vivo and high glucose in vitro diminish GAPDH activity in rat embryos.
    Wentzel P; Ejdesjö A; Eriksson UJ
    Diabetes; 2003 May; 52(5):1222-8. PubMed ID: 12716756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered mitochondrial morphology of rat embryos in diabetic pregnancy.
    Yang X; Borg LA; Eriksson UJ
    Anat Rec; 1995 Feb; 241(2):255-67. PubMed ID: 7710141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection by free oxygen radical scavenging enzymes against glucose-induced embryonic malformations in vitro.
    Eriksson UJ; Borg LA
    Diabetologia; 1991 May; 34(5):325-31. PubMed ID: 1864487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-hydroxybutyrate increases reactive oxygen species in late but not in early postimplantation embryonic cells in vitro.
    Forsberg H; Eriksson UJ; Melefors O; Welsh N
    Diabetes; 1998 Feb; 47(2):255-62. PubMed ID: 9519722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal diabetes in vivo and high glucose concentration in vitro increases apoptosis in rat embryos.
    Gäreskog M; Cederberg J; Eriksson UJ; Wentzel P
    Reprod Toxicol; 2007 Jan; 23(1):63-74. PubMed ID: 17034987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Teratogenic effect of diabetic serum is prevented by supplementation of superoxide dismutase and N-acetylcysteine in rat embryo culture.
    Wentzel P; Thunberg L; Eriksson UJ
    Diabetologia; 1997 Jan; 40(1):7-14. PubMed ID: 9028712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin treatment fails to abolish the teratogenic potential of serum from diabetic rats.
    Wentzel P; Eriksson UJ
    Eur J Endocrinol; 1996 Apr; 134(4):459-66. PubMed ID: 8640298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A diabetes-like environment increases malformation rate and diminishes prostaglandin E(2) in rat embryos: reversal by administration of vitamin E and folic acid.
    Wentzel P; Eriksson UJ
    Birth Defects Res A Clin Mol Teratol; 2005 Jul; 73(7):506-11. PubMed ID: 15959876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antioxidants diminish developmental damage induced by high glucose and cyclooxygenase inhibitors in rat embryos in vitro.
    Wentzel P; Eriksson UJ
    Diabetes; 1998 Apr; 47(4):677-84. PubMed ID: 9568703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of embryonic dysmorphogenesis by high glucose concentration, disturbed inositol metabolism, and inhibited protein kinase C activity.
    Wentzel P; Wentzel CR; Gäreskog MB; Eriksson UJ
    Teratology; 2001 May; 63(5):193-201. PubMed ID: 11320530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of reactive oxygen species (ROS) in the diabetes-induced anomalies in rat embryos in vitro: reduction in antioxidant enzymes and low-molecular-weight antioxidants (LMWA) may be the causative factor for increased anomalies.
    Ornoy A; Zaken V; Kohen R
    Teratology; 1999 Dec; 60(6):376-86. PubMed ID: 10590399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered levels of scavenging enzymes in embryos subjected to a diabetic environment.
    Forsberg H; Borg LA; Cagliero E; Eriksson UJ
    Free Radic Res; 1996 Jun; 24(6):451-9. PubMed ID: 8804988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pregnant diabetic rats fed the antioxidant butylated hydroxytoluene show decreased occurrence of malformations in offspring.
    Eriksson UJ; Simán CM
    Diabetes; 1996 Nov; 45(11):1497-502. PubMed ID: 8866552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetic embryopathy: studies using a rat embryo culture system and an animal model.
    Akazawa S
    Congenit Anom (Kyoto); 2005 Sep; 45(3):73-9. PubMed ID: 16131363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.